The cellular retinoic acid binding proteins

The two cellular retinoic acid binding proteins, CRABP I and CRABP II, belong to a family of small cytosolic lipid binding proteins and are highly conserved during evolution. Both proteins are expressed during embryogenesis, particularly in the developing nervous system, craniofacial region and limb bud. CRABP I is also expressed in several adult tissues, however, in contrast, CRABP II expression appears to be limited to the skin. It is likely that these proteins serve as regulators in the transport and metabolism of retinoic acid in the developing embryo and throughout adult life. It has been proposed that CRABP I sequesters retinoic acid in the cytoplasm and prevents nuclear uptake of retinoic acid. A role in catabolism of retinoic acid has also been proposed. Recent gene targeting experiments have shown that neither of the two CRABPs are essential for normal embryonic development or adult life. Examination of CRABP I expression at subcellular resolution reveals a differential cytoplasmic and/or nuclear localization of the protein. A regulated nuclear uptake of CRABP I implies a role for this protein in the intracellular transport of retinoic acid. A protein mediated mechanism which controls the nuclear uptake of retinoic acid may play an important role in the transactivation of the nuclear retinoic acid receptors.     

Accessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumours

Immunohistochemical studies of the hyaluronan (HA)-receptor (R), originally found on liver endothelial cells (LEC) and related to the intercellular adhesion molecule 1 (ICAM-1), showed that polyclonal antibodies against HARLEC (HA receptor on LEC) also stain structures in mouse mastocytomas, mainly vessels. To test if intravenously administered HA might target the tumour receptorsin vivo, mice carrying an inoculated mastocytoma in one hind leg muscle were injected in the tail vein with¹²⁵I-tyrosine (T)-labelled HA and killed 75 min after injection when organs and tissues were checked for radioactivity. When doses exceeding the binding capacity of the liver were injected, a significant increase in radioactivity (up to five-fold) within the tumour tissue was found. The weight adjusted difference between control and tumour tissue was greater for smaller tumours, probably due to necrosis in the larger. HA-staining of tumours from animals receiving¹²⁵I-T-HA, showed HA in areas that also stained weakly for ICAM-1 using monoclonal antibodies. ICAM-1 staining was dramatically increased after hyaluronidase treatment of the sections, indicating that the HA is bound to these receptors and thereby blocks antibody recognition.Abbreviations ICAM-1 intercellular adhesion molecule 1 - HA hyaluronan - HARLEC hyaluronan receptor on liver endothelial cells - MW molecular weight     

EXCYSTMENT AND GROWTH OF CHRYSOPHYTES AND DINOFLAGELLATES AT LOW TEMPERATURES AND HIGH SALINITIES IN ANTARCTIC SEA-ICE1

Extreme environmental conditions have been thought to limit algal growth in the upper sea-ice. In McMurdo Sound, Antarctica, chrysophyte statocysts (stomatocysts) and dinoflagellate hypnozygotes (resting cysts) overwinter in first- and second-year land-fast sea-ice exposed to temperatures of -20° C or lower. In early November, when temperatures in the upper ice are < ?8°C and brine salinities are >126 psu, dinoflagellate cysts activate and shortly thereafter excyst. During early November, chrysophyte statocysts also begin to excyst. Net daily primary production occurs in the sea-ice brine at temperatures as low as ?7.1° C, at brine salinities as high as 129 psu, and at average photon flux densities as low as 5 μmol photons.m^?2.s^?1. Dinoflagellate densities were >10⁶ vegetative cells.L^?1 of ice while temperatures in the upper ice were between ?6.8 and ?5.8° C and brine salinities were ～100 psu. Chrysophyte densities reached >10⁶.L^?1 of ice by early December. High densities of physiologically active clyo- and halotolerant algae can occur in the upper land-fast sea-ice under extreme conditions of temperature and salinity.     

Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.

Activation of the tyrosine kinase JAK2 is an essential step in cellular signaling by growth hormone (GH) and multiple other hormones and cytokines. Murine JAK2 has a total of 49 tyrosines which, if phosphorylated, could serve as docking sites for Src homology 2 (SH2) or phosphotyrosine binding domain-containing signaling molecules. Using a yeast two-hybrid screen of a rat adipocyte cDNA library, we identified a splicing variant of the SH2 domain-containing protein SH2-B, designated SH2-Bbeta, as a JAK2-interacting protein. The carboxyl terminus of SH2-Bbeta (SH2-Bbetac), which contains the SH2 domain, specifically interacts with kinase-active, tyrosyl-phosphorylated JAK2 but not kinase-inactive, unphosphorylated JAK2 in the yeast two-hybrid system. In COS cells coexpressing SH2-Bbeta or SH2-Bbetac and murine JAK2, both SH2-Bbetac and SH2-Bbeta coimmunoprecipitate to a significantly greater extent with wild-type, tyrosyl-phosphorylated JAK2 than with kinase-inactive, unphosphorylated JAK2. SH2-Bbetac also binds to immunoprecipitated wild-type but not kinase-inactive JAK2 in a far Western blot. In 3T3-F442A cells, GH stimulates the interaction of SH2-Bbeta with tyrosyl-phosphorylated JAK2 both in vitro, as assessed by binding of JAK2 in cell lysates to glutathione S-transferase (GST)-SH2-Bbetac or GST-SH2-Bbeta fusion proteins, and in vivo, as assessed by coimmunoprecipitation of JAK2 with SH2-Bbeta. GH promoted a transient and dose-dependent tyrosyl phosphorylation of SH2-Bbeta in 3T3-F442A cells, further suggesting the involvement of SH2-Bbeta in GH signaling. Consistent with SH2-Bbeta being a substrate of JAK2, SH2-Bbetac is tyrosyl phosphorylated when coexpressed with wild-type but not kinase-inactive JAK2 in both yeast and COS cells. SH2-Bbeta was also tyrosyl phosphorylated in response to gamma interferon, a cytokine that activates JAK2 and JAK1. These data suggest that GH-induced activation and phosphorylation of JAK2 recruits SH2-Bbeta and its associated signaling molecules into a GHR-JAK2 complex, thereby initiating some as yet unidentified signal transduction pathways. These pathways are likely to be shared by other cytokines that activate JAK2.     

The influence of sulfated polysaccharides on the circulating levels of hyaluronan

When chondroitin sulfate (CS) or dextran sulfate (DxS) was administeredintravenously in rats the levels of circulating hyaluronan (HA)rapidly increased, 70 min after injection the levels were foundto be about 10–20 times the initial values. Saline injectionswere without effect on HA levels. CS given intraperitoneallywas found to give prolonged blocking of liver uptake of labeledHA and increased endogenous serum HA to about 10 times the initiallevel at 180 min. HA excretion in urine was dramatically increasedby CS given intravenously, intraperitoneally as well as subcutaneously.Size-exclusion chromatography showed a mean MW of the circulatingHA of around 50 kDa while urinary HA had a mean MW of about10 kDa. Circulating HA has previously been shown to be veryeffectively cleared via receptor mediated endocytosis by re-ticuloendothelialcells, primarily liver endothelial cells. As CS and DxS bindto the same receptors and inhibits HA clearance, the effectsof sulfated polysaccharides on inflammatory conditions and angiogenesismight be via HA, previously shown to affect these processes.Such a mechanism could also explain increased HA levels as asecondary event to increased CS and other sulfated biologicalpolysaccharides in some physiological and pathological conditions. hyaluronic acid turnover metabolism glycosaminoglycans angiogenesis     

Hypothesis Testing for an Exposure–Disease Association in Case–Control Studies Under Nondifferential Exposure Misclassification in the Presence of Validation Data: Bayesian and Frequentist Adjustments

In epidemiologic studies, measurement error in the exposure variable can have a detrimental effect on the power of hypothesis testing for detecting the impact of exposure in the development of a disease. To adjust for misclassification in the hypothesis testing procedure involving a misclassified binary exposure variable, we consider a retrospective case–control scenario under the assumption of nondifferential misclassification. We develop a test under Bayesian approach from a posterior distribution generated by a MCMC algorithm and a normal prior under realistic assumptions. We compared this test with an equivalent likelihood ratio test developed under the frequentist approach, using various simulated settings and in the presence or the absence of validation data. In our simulations, we considered varying degrees of sensitivity, specificity, sample sizes, exposure prevalence, and proportion of unvalidated and validated data. In these scenarios, our simulation study shows that the adjusted model (with-validation data model) is always better than the unadjusted model (without validation data model). However, we showed that exception is possible in the fixed budget scenario where collection of the validation data requires a much higher cost. We also showed that both Bayesian and frequentist hypothesis testing procedures reach the same conclusions for the scenarios under consideration. The Bayesian approach is, however, computationally more stable in rare exposure contexts. A real case–control study was used to show the application of the hypothesis testing procedures under consideration.     

Endothelial cell junctions

In the course of a freeze-cleave study on intercellular junctions in the regenerating rat liver, we observed an unusual array of intramembranous particles located in regions of contact between endothelial cells lining the hepatic sinusoids. These arrays were characterized by an accumulation of particles which resembled a zonula occludens in their linear deployment but differed in that the contact regions were composed of individual particles which remained separated from each other by regular particle-free intervals.